Literature DB >> 1565474

Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene.

G R Mazars1, P Jeanteur, H T Lynch, G Lenoir, C Theillet.   

Abstract

By screening for mutations in the p53 coding sequence by means of single-strand conformation polymorphism (SSCP) in a series of breast tumors we detected a novel polymorphism. This change in the SSCP pattern was detected in 6.2% of the tumor DNAs analysed and implied an A to G substitution at the last base of codon 213, thus representing a neutral change. First suspecting a somatic mutation we confirmed its presence in matched sets of DNAs from normal tissues. Extending our study to a series of 60 ovarian carcinomas and 70 healthy blood donors we noticed that this polymorphism represented only 3% and 2.6% respectively. We wondered if the difference in frequency in the breast cancer population might not be related to familial breast cancer and analysed 26 DNAs from patients showing predisposition to the disease. Two patients presented this polymorphism and one corresponding kindred was analysed, revealing a mendelian mode of transmission but no correlation with the cancer phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1565474

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.

Authors:  T J Bromidge; D J Howe
Journal:  Mol Pathol       Date:  2000-08

2.  Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma.

Authors:  K Segers; H Backhovens; S K Singh; J De Voecht; M Ramael; C Van Broeckhoven; E Van Marck
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Romy Zemel; Claud Koren; Larisa Bachmatove; Smadar Avigad; Ella Kaganovsky; Elimelech Okon; Ziv Ben-Ari; Franklin Grief; Merav Ben-Yehoyada; Yosef Shaul; Ran Tur-Kaspa
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

4.  Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.

Authors:  H M Warenius; M Jones; T Gorman; R McLeish; L Seabra; R Barraclough; P Rudland
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

5.  Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.

Authors:  R Abdel-Fattah; C Challen; T R Griffiths; M C Robinson; D E Neal; J Lunec
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

6.  Analysis of R213R and 13494 g-->a polymorphisms of the p53 gene in individuals with esophagitis, intestinal metaplasia of the cardia and Barrett's Esophagus compared with a control group.

Authors:  Diogo André Pilger; Patrícia Luciana da Costa Lopez; Fábio Segal; Sandra Leistner-Segal
Journal:  Genomic Med       Date:  2007-05-25

7.  p53 mutations have no additional prognostic value over stage in bladder cancer.

Authors:  J A Vet; P P Bringuier; P J Poddighe; H F Karthaus; F M Debruyne; J A Schalken
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.